Inission

Inission

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

Inission - Momentum to persist throughout 2026

10 maj 2026

  • Sales up 37% y-o-y as adj. EBITA more than doubled
  • Continued order momentum drives estimate upgrades
  • Enedo recovering, M&A and Tunis factory to add further growth

Q1 results

The earnings-growth trend that started in Q3 accelerated in Q1. Sales were up 37% y-o-y (11% M&A), while the book-to-bill stayed at a very healthy 1.1x. With the adj. EBITA margin expanding to 7.0% (4.8%), earnings more than doubled y-o-y, beating our estimate by 10%. Management attributed the strong growth to increased momentum in the defence, data centre, and quantum computing end markets. Importantly, Inission Power (Enedo) demonstrated strong growth, a great book-to-bill of 1.3x, and decent profitability of 3.1% (-2.8%), which is the first time since Q3'24 that it reached this margin on an unadjusted basis.

Estimate changes

The earnings beat and surprisingly persistent order intake momentum drive us to raise '26e-'28e adj. EBITA by 5%. This puts us above the high end of the company's guidance range for '26 (SEK 2.3-2.5bn sales, >6% EBITA margin), but we think this is warranted given the strong start to the year and management's indication during the earnings call that the guidance is on the conservative side.

Outlook and valuation

Management said that the raised geopolitical uncertainty does not seem to have curbed the budding macroeconomic recovery; it has, however, impacted the component market, but the company is working with its suppliers to mitigate this. Given the recent order intake, the company sees good chances for the strong start of the year to persist throughout '26, as do we. M&A remains an active part of the strategy, with some processes making progress during the quarter, and we view an acquisition this year as likely, which would boost growth further. The company is also in discussions with several potential customers for the Tunis factory, something that should further help earnings in the medium term. The share is trading at 14-10x the '26e-'28e P/Es, vs. Nordic peers at 17-14x.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-15 Svedbergs Group - Logistics drag persists into H2 Svedbergs G.. Analys
2026-07-15 Infrea - Strong quarter but pegged to Netel Infrea Analys
2026-07-15 Coor - Solid earnings despite softer sales Coor Analys
2026-07-15 Svedbergs Group - Nordics and one-offs weigh Svedbergs G.. Analys
2026-07-14 Nexam Chemical - Solid Q2, profitability within r... Nexam Chemical Analys
2026-07-14 Nexam Chemical - Record sales and first positive ... Nexam Chemical Analys
2026-07-14 Eastnine - Warsaw to become the largest market Eastnine Analys
2026-07-13 Ascelia Pharma - CRL update Ascelia Pharma Analys
2026-07-13 Medicover - Steady as she goes Medicover Analys
2026-07-13 Arctic Paper - Pulp beats paper Arctic Paper Analys
2026-07-13 Studsvik - Gearing up for the new-build era Studsvik Analys
2026-07-10 StrongPoint - The American dream StrongPoint Analys
2026-07-10 Careium - The pressure valve starting to open Careium Analys
2026-07-10 StrongPoint - Solid Q2 performance StrongPoint Analys
2026-07-10 Careium - Growth's comeback tour continues Careium Analys
2026-07-09 Infrea - Road tripping with Netel Infrea Analys
2026-07-08 Alligo - Softer growth, but margin recovery conti... Alligo Analys
2026-07-08 Qliro - Key earnings drivers intact Qliro Analys
2026-07-07 Nexam Chemical - We expect a firmer sequential qu... Nexam Chemical Analys
2026-07-07 Eastnine - Adding in Warsaw Eastnine Analys